HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BRAF plus MEK inhibition effective in papillary craniopharyngioma.

AuthorsPeter Sidaway
JournalNature reviews. Clinical oncology (Nat Rev Clin Oncol) Vol. 20 Issue 10 Pg. 661 (10 2023) ISSN: 1759-4782 [Electronic] England
PMID37491596 (Publication Type: Journal Article)
Chemical References
  • BRAF protein, human
  • Mitogen-Activated Protein Kinase Kinases
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins B-raf
Topics
  • Humans
  • Craniopharyngioma (drug therapy, genetics)
  • Mitogen-Activated Protein Kinase Kinases (antagonists & inhibitors)
  • Mutation
  • Pituitary Neoplasms (drug therapy, genetics)
  • Protein Kinase Inhibitors (therapeutic use)
  • Proto-Oncogene Proteins B-raf (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: